UPI reports scientists have made a breakthrough in the fight against the deadly Ebola virus.
University of Texas Medical Branch researchers say they've developed a single dose treatment.
The two-antibody combination drug, called MBP134, has shown promise for combating all forms of the Ebola virus.
It was successful against several strains of Ebola, including the Zaire strain behind the current months-long outbreak in Congo.
Our experimental drug can protect against all forms of Ebola known to harm people, suggesting that it will continue to protect people if the Ebola viruses evolve over time.
Professor Thomas Geisbert, Ebola researcher
University of Texas Medical Branch